Oral benzo[a]pyrene in Cyp1 knockout mouse lines:: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate

被引:176
作者
Uno, S
Dalton, TP
Dragin, N
Curran, CP
Derkenne, S
Miller, ML
Shertzer, HG
Gonzalez, FJ
Nebert, DW
机构
[1] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA
[3] Nihon Univ, Sch Med, Dept Biochem, Tokyo, Japan
[4] NIH, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD USA
关键词
D O I
10.1124/mol.105.021501
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP1A1 and CYP1B1 metabolically activate many polycyclic aromatic hydrocarbons (PAHs), including benzo[a] pyrene, to reactive intermediates associated with toxicity, mutagenesis, and carcinogenesis. Paradoxically, however, Cyp1a1(-/-) knockout mice are more sensitive to oral benzo[ a] pyrene exposure, compared with wild-type Cyp1a1(-/-) mice ( Mol Pharmacol 65: 1225, 2004). To further investigate the mechanism for this enhanced sensitivity, Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1b1(-/-) single-knockout, Cyp1a1/1b1(-/-) and Cyp1a2/1b1(-/-) double-knockout, and Cyp1(-/-) wild-type mice were analyzed. After administration of oral benzo[ a] pyrene ( 125 mg/kg/day) for 18 days, Cyp1a1(-/-) mice showed marked wasting, immunosuppression, and bone marrow hypocellularity, whereas the other five genotypes did not. After 5 days of feeding, steady-state blood levels of benzo[ a] pyrene were similar to 25 and similar to 75 times higher in Cyp1a1(-/-) and Cyp1a1/1b1(-/-) mice, respectively, than in wild-type mice. Benzo[ a] pyrene-DNA adduct levels were highest in liver, spleen, and marrow of Cyp1a1(-/-) and Cyp1a1/1b1(-/-) mice. Many lines of convergent data obtained with oral benzo[ a] pyrene dosing suggest that: 1) inducible CYP1A1, probably in both intestine and liver, is most important in detoxication; 2) CYP1B1 in spleen and marrow is responsible for metabolic activation of benzo[a] pyrene, which results in immune damage in the absence of CYP1A1; 3) both thymus atrophy and hepatocyte hypertrophy are independent of CYP1B1 metabolism but rather may reflect long-term activation of the aryl hydrocarbon receptor; and 4) the magnitude of immune damage in Cyp1a1(-/-) and Cyp1a1/1b1(-/-) mice is independent of plasma benzo[a] pyrene and total-body burden and clearance. Thus, a balance between tissue-specific expression of the CYP1A1 and CYP1B1 enzymes governs sensitivity of benzo[a] pyrene toxicity and, possibly, carcinogenicity.
引用
收藏
页码:1103 / 1114
页数:12
相关论文
共 51 条
  • [1] CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung:: comparison with aromatic/hydrophobic adduct formation
    Alexandrov, K
    Cascorbi, I
    Rojas, M
    Bouvier, G
    Kriek, E
    Bartsch, H
    [J]. CARCINOGENESIS, 2002, 23 (12) : 1969 - 1977
  • [2] Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes
    Buesen, R
    Mock, M
    Seidel, A
    Jacob, J
    Lampen, A
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 183 (03) : 168 - 178
  • [3] Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas
    Buters, JTM
    Sakai, S
    Richter, T
    Pineau, T
    Alexander, DL
    Savas, U
    Doehmer, J
    Ward, JM
    Jefcoate, CR
    Gonzalez, FJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 1977 - 1982
  • [4] STUDIES ON THE METABOLISM OF BENZO[A]PYRENE AND DOSE-DEPENDENT DIFFERENCES IN THE MUTAGENIC PROFILE OF ITS ULTIMATE CARCINOGENIC METABOLITE
    CONNEY, AH
    CHANG, RL
    JERINA, DM
    WEI, SJC
    [J]. DRUG METABOLISM REVIEWS, 1994, 26 (1-2) : 125 - 163
  • [5] Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery
    Dalton, TP
    Dieter, MZ
    Matlib, RS
    Childs, NL
    Shertzer, HG
    Genter, MB
    Nebert, DW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (01) : 184 - 189
  • [6] Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization
    Dey, A
    Jones, JE
    Nebert, DW
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (03) : 525 - 537
  • [7] THE USE OF GENETICALLY ENGINEERED V79 CHINESE-HAMSTER CULTURES EXPRESSING RAT-LIVER CYP1A1, 1A2 AND 2B1 CDNAS IN MICRONUCLEUS ASSAYS
    ELLARD, S
    MOHAMMED, Y
    DOGRA, S
    WOLFEL, C
    DOEHMER, J
    PARRY, JM
    [J]. MUTAGENESIS, 1991, 6 (06) : 461 - 470
  • [8] Falcon MSG, 1996, FOOD ADDIT CONTAM, V13, P863
  • [9] REGIOSPECIFIC EXPRESSION OF CYTOCHROME-P-450S AND MICROSOMAL EPOXIDE HYDROLASE IN HUMAN BRAIN-TISSUE
    FARIN, FM
    OMIECINSKI, CJ
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1993, 40 (2-3): : 317 - 335
  • [10] Cytochrome P4502C is an EDHF synthase in coronary arteries
    Fisslthaler, B
    Popp, R
    Kiss, L
    Potente, M
    Harder, DR
    Fleming, I
    Busse, R
    [J]. NATURE, 1999, 401 (6752) : 493 - 497